Show Summary Details
Page of

Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study 

Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study
Chapter:
Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study
Author(s):

Kevin Johnson

, and Srinivas Muvvala

DOI:
10.1093/med/9780190625085.003.0049
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 August 2019

This chapter provides a summary of the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence Study. This landmark study researches the efficacy of medications, behavioral therapies, and their combinations in the treatment of alcohol use disorder. Starting with the research question, this review describes the basics of the study, including funding, study location, who was studied, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. One key finding is the efficacy of naltrexone at lowering the number of heavy alcohol consumption days. The chapter briefly reviews other relevant studies and information, discusses implications, provides clinical guidelines, and concludes with a relevant clinical case.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.